Therefore, dual DDAH1/arginase inhibition is proposed as be a useful strategy for selectively targeting tumor growth in multiple cancer phenotypes11,43–45 whilst maintaining NO homeostasis in healthy cells. This evidence concerns the gene DDAH1 and cancer.